IP Library › Granted Patent US 12,577,544
Granted Patent B2
US 12,577,544 · App. 19/019,039 · Granted Mar 17, 2026

Modified PH129 polymerase and uses thereof

Inventors: Souad Naji (La Jolla, CA); Alexander Sevy (San Diego, CA); Jason Cellitti (San Diego, CA); Eli N. Glezer (Del Mar, CA); Bruna Krebs Kutche (San Diego, CA); Zachary Terranova (San Diego, CA); Sumit Handa (San Diego, CA)
Assignee: Singular Genomics Systems, Inc.
C12N9/1252C12Q1/6844C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,577,544
App. No.
19/019,039
Filed
Jan 13, 2025
Granted
Mar 17, 2026
Kind
B2
Art Unit
1652
USPC
435/194
Abstract

Disclosed herein, inter alia, are mutant enzymes, kits, and methods of use thereof.

Claims (24)

1 . A polymerase comprising an amino acid sequence that is at least 90% identical to SEQ ID NO: 1; comprising an amino acid substitution, wherein said amino acid substitution is A324T, A394G, A394K, A394N, A394Q, A394V D219N, D34A, D34E, D34N, D34Q, F198L, F47I, G401A, G401L, G401V, G417A, G417K, G417N, G417Q, G417R, G579A, G579S, G579T, G579Y, H485L, I119A, I119G, I119L, I119V, I179F, I378A, I378G, I378L, I378V, I93A, I93G, I93N, I93Q, K135G, K311N, K311Q, K311R, K366A, K366G, K366H, K366N, K366Q, K366R, L216A, L216F, L216G, L216P, L216W, L216Y, L381Q, L462A, L462G, L462I, L462V, L567M, P87A, P87G, P87S, P87T, P87Y, R552A, R552N, R552Q, S192A, S192C, S192G, S260N, S260Q, S487C, S578A, S578G, S578I, S578L, S578T, S578V, T203S, T231A, T231I, T231V, T434A, T434G, T434Y, V565A, V565G, V565M, W436R, Y343C, Y500A, Y500F, or Y500G.

2 . The polymerase of claim 1 , wherein said the amino acid substitution is:

D34E, F47I, P87S, I93N, I119V, I179F, S192C, F198L, T203S, D219N, T231I, K311R, A324T, Y343C, K366R, I378V, L381Q, A394V, G401V, G417R, L462I, H485L, S487C, Y500F, K539E, R552Q, V565M, L567M, S578G, or G579S.

3 . A method of incorporating a nucleotide into a nucleic acid sequence comprising combining in a reaction vessel: (i) a nucleic acid template, (ii) a nucleotide solution comprising a plurality of nucleotides, and (iii) a polymerase, wherein the polymerase is a polymerase of claim 1 .

4 . A method of amplifying a nucleic acid sequence, said method comprising:

a) hybridizing a nucleic acid template to a primer to form a primer-template hybridization complex;

b) contacting said primer-template hybridization complex with a DNA polymerase and a plurality of nucleotides, wherein the DNA polymerase is the polymerase of claim 1 ; and

c) subjecting the primer-template hybridization complex to conditions which enable the polymerase to incorporate one or more nucleotides into the primer-template hybridization complex to generate amplification products, thereby amplifying a nucleic acid sequence.

5 . A method of amplifying a template polynucleotide, the method comprising: contacting a template polynucleotide with an amplification primer, and amplifying the template polynucleotide by extending an amplification primer with a polymerase to generate an extension product comprising one or more complements of the template polynucleotide; wherein said polymerase is a polymerase of claim 1 .

6 . The method of claim 5 , comprising amplifying the template polynucleotide in a cell.

7 . The method of claim 5 , comprising amplifying the template polynucleotide in a tissue.

8 . The method of claim 5 , comprising amplifying the template polynucleotide on a solid support.

9 . The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, or glycine at an amino acid position corresponding to position 135.

10 . The polymerase of claim 1 , further comprising K135E.

11 . The polymerase of claim 1 , comprising G417A, G417K, G417N, or G417Q.

12 . The polymerase of claim 1 , comprising A394V or A394K.

13 . The polymerase of claim 1 , further comprising K536E.

14 . The polymerase of claim 1 , comprising P87S and I93N.

15 . The polymerase of claim 14 , further comprising I378V, and S578V.

16 . The polymerase of claim 1 , comprising L381Q and H485L.

17 . The polymerase of claim 1 , further comprising P87A, P87G, P87S, P87T, or P87Y.

18 . The polymerase of claim 1 , comprising F198L.

19 . The polymerase of claim 1 , comprising G417R.

20 . The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, or glycine at an amino acid position corresponding to position 135; and a glutamic acid, aspartic acid, alanine, glycine, or threonine at an amino acid position corresponding to position 536.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2025
From: NAJI, SOUAD; SEVY, ALEXANDER; CELLITTI, JASON; GLEZER, ELI N.; KUTCHE, BRUNA KREBS; TERRANOVA, ZACHARY L.; HANDA, SUMIT
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 073344/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2025
From: SEVY, ALEXANDER; NAJI, SOUAD; CELLITTI, JASON; TERRANOVA, ZACHARY; KUTCHE, BRUNA KREBS; GLEZER, ELI N.; HANDA, SUMIT
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 070247/0182 →
Continuity (7)
Continuation 18659585 · May 9, 2024
Continuation PCTUS2023075838 · Oct 3, 2023
Provisional Application 63378223 · Oct 3, 2022
Provisional Application 63493180 · Mar 30, 2023
Provisional Application 63502005 · May 12, 2023
Provisional Application 63580874 · Sep 6, 2023
Related Publication 20250320474A1 · Oct 16, 2025
References Cited (29)
US 5001050A · Blanco et al. · 1991 [cited by applicant]
US 5198543A · Blanco et al. · 1993 [cited by applicant]
US 5576204A · Blanco et al. · 1996 [cited by applicant]
US 8343746B2 · Rank et al. · 2013 [cited by applicant]
US 8906660B2 · Kamtekar et al. · 2014 [cited by applicant]
US 9296999B2 · Kamtekar et al. · 2016 [cited by applicant]
US 9422535B2 · Skirgaila et al. · 2016 [cited by applicant]
US 9758774B2 · Kamtekar et al. · 2017 [cited by applicant]
US 11371028B2 · Ong et al. · 2022 [cited by applicant]
US 12227774B2 · Naji · 2025 [cited by examiner]
US 20080108082A1 · Rank et al. · 2008 [cited by applicant]
US 20110059505A1 · Hanzel et al. · 2011 [cited by applicant]
US 20110165652A1 · Hardin et al. · 2011 [cited by applicant]
US 20210261928A1 · Kamtekar et al. · 2021 [cited by applicant]
US 20220235337A1 · Picher Serantes et al. · 2022 [cited by applicant]
US 20220235410A1 · Witters et al. · 2022 [cited by applicant]
US 20240294887A1 · Naji et al. · 2024 [cited by applicant]
Accession P03680. (Jul. 21, 1986). [cited by applicant]
Bornscheuer, U. et al. (Nov. 1, 2011). “Survey of protein engineering strategies,” [cited by applicant]
Chica, R. A. et al. (Aug. 2005, e-published Jul. 1, 2005). “Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design,” [cited by applicant]
De Vega, M. et al. (Sep. 21, 2010, e-published Sep. 7, 2010). “Improvement of q29 DNA polymerase amplification performance by fusion of DNA binding motifs,” [cited by applicant]
Gao, Y. et al. (Jul. 2021, e-published May 19, 2021). “Chimeric Phi29 DNA polymerase with helix-hairpin-helix motifs shows enhanced salt tolerance and replication performance,” [cited by applicant]
International Search Report and Written Opinion mailed on Apr. 12, 2024, for PCT Application No. PCT/US2023/075838, filed Oct. 3, 2023, 15 pages. [cited by applicant]
Li, Y. et al. (Jul. 2014, e-published May 6, 2014). “Recent advances in engineering proteins for biocatalysis,” [cited by applicant]
Lizardi, P. M. et al. (Jul. 1998). “Mutation detection and single-molecule counting using isothermal rolling-circle amplification,” [cited by applicant]
Meijer, W. J. J. et al. (Jun. 1, 2001). “29 family of phages,” [cited by applicant]
Povilaitis, T. et al. (Dec. 28, 2016, e-published Nov. 28, 2016). “In vitro evolution of phi29 DNA polymerase using isothermal compartmentalized self replication technique,” [cited by applicant]
Salas, M. (Dec. 15, 2016). “My scientific life,” [cited by applicant]
Singh, K. et al. (Jan. 1, 2018). “Protein engineering approaches in the post-genomic era,” [cited by applicant]